Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002595253 | SCV003493258 | pathogenic | Peroxisome biogenesis disorder 2B | 2023-03-23 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 2177642). This variant has not been reported in the literature in individuals affected with PEX5-related conditions. This variant is present in population databases (rs751148574, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Thr316Leufs*73) in the PEX5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX5 are known to be pathogenic (PMID: 18712838, 21031596). |
Fulgent Genetics, |
RCV005011022 | SCV005629188 | likely pathogenic | Peroxisome biogenesis disorder 2B; Peroxisome biogenesis disorder 2A (Zellweger); Rhizomelic chondrodysplasia punctata type 5 | 2024-06-17 | criteria provided, single submitter | clinical testing |